How Does Antimicrobial Stewardship Affect Inappropriate Antibiotic Therapy in Urological Patients?

antimicrobial stewardship team intervention urological patient

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
06 Feb 2020
Historique:
received: 19 01 2020
accepted: 03 02 2020
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 12 2 2020
Statut: epublish

Résumé

Antimicrobial stewardship teams (ASTs) have been well-accepted in recent years; however, their clinical outcomes have not been fully investigated in urological patients. The purpose of this study was to evaluate the outcomes of intervention via a retrospective review of urological patients, as discussed in the AST meetings, who were treated with broad-spectrum antibiotics between 2014 and 2018 at the Department of Urology, Kobe University Hospital in Japan. Interventions were discussed in AST meetings for patients identified by pharmacists as having received inappropriate antibiotic therapy. The annual changes in numbers of inappropriate medications and culture submissions over five years at the urology department were statistically analyzed. Among 1,033 patients audited by pharmacists, inappropriate antibiotic therapy was found in 118 cases (11.4%). The numbers of inappropriate antibiotic use cases and of interventions for indefinite infections had significantly decreased during the study period (

Identifiants

pubmed: 32041102
pii: antibiotics9020063
doi: 10.3390/antibiotics9020063
pmc: PMC7168275
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Epidemiol. 2012;22(2):86-90
pubmed: 22307433
N Engl J Med. 2003 Jan 9;348(2):138-50
pubmed: 12519925
Rev Esp Quimioter. 2018 Apr;31(2):110-117
pubmed: 29521484
Front Microbiol. 2015 Jun 03;6:546
pubmed: 26089819
J Infect Chemother. 2018 Oct;24(10):807-811
pubmed: 30037758
Clin Microbiol Rev. 2016 Dec 14;30(1):381-407
pubmed: 27974411
Jpn J Infect Dis. 2019 Jan 23;72(1):56-57
pubmed: 30175738
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29109168
Am J Infect Control. 2016 Dec 1;44(12):1549-1553
pubmed: 27388268
Clin Pediatr (Phila). 2017 Jul;56(8):744-751
pubmed: 27872355
Antimicrob Resist Infect Control. 2015 Dec 01;4:54
pubmed: 26634119
J Infect Chemother. 2018 Mar;24(3):206-211
pubmed: 29141775
J Glob Antimicrob Resist. 2014 Dec;2(4):245-253
pubmed: 27873683
Int J Urol. 2014 Jul;21(7):628-9
pubmed: 24641085
Clin Infect Dis. 2017 May 15;64(suppl_2):S112-S114
pubmed: 28475788
Infection. 2018 Apr;46(2):215-224
pubmed: 29134582
Clin Microbiol Infect. 2018 Jan;24(1):82.e5-82.e10
pubmed: 28506783
Clin Infect Dis. 2014 Jan;58(2):164-9
pubmed: 24158412
Clin Microbiol Rev. 2005 Oct;18(4):638-56
pubmed: 16223951

Auteurs

Atsushi Uda (A)

Department of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Department of Pharmacy, Kobe University Hospital, Kobe 650-0017, Japan.

Katsumi Shigemura (K)

Department of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Division of Infectious Diseases, Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
Division of Urology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Koichi Kitagawa (K)

Division of Infectious Diseases, Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
Division of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe 657-8501, Japan.

Kayo Osawa (K)

Division of Infectious Diseases, Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
Department of Medical Technology, Kobe Tokiwa University, Kobe 653-0838, Japan.

Kenichiro Onuma (K)

Department of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.

Shigeaki Inoue (S)

Department of Disaster and Emergency Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Joji Kotani (J)

Department of Disaster and Emergency Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Yonmin Yan (Y)

Division of Urology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Yuzo Nakano (Y)

Division of Urology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Tatsuya Nishioka (T)

Department of Pharmacy, Kobe University Hospital, Kobe 650-0017, Japan.

Ikuko Yano (I)

Department of Pharmacy, Kobe University Hospital, Kobe 650-0017, Japan.

Takayuki Miyara (T)

Department of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.

Masato Fujisawa (M)

Division of Urology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Classifications MeSH